|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 253.87 USD | -0.39% |
|
+4.83% | +49.34% |
| 07-17 | Canaccord Genuity Initiates Coverage on Jazz Pharmaceuticals With Buy Rating, $290 Price Target | MT |
| 07-10 | Biopharma Pricing Power Seen as Key Swing Factor for Q2 Earnings, BofA Says | MT |
| Market Cap | 16.01B 14.08B 13.09B 12.02B 22.56B 1,546B 22.94B 155B 60.72B 758B 60.1B 58.8B 2,622B | P/E 2026 * |
18x | P/E 2027 * | 16.3x |
|---|---|---|---|---|---|
| Enterprise Value | 17.71B 15.58B 14.48B 13.3B 24.95B 1,710B 25.37B 172B 67.16B 838B 66.47B 65.04B 2,901B | EV / Sales 2026 * |
3.92x | EV / Sales 2027 * | 3.31x |
| Free-Float |
96.65% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Jazz Pharmaceuticals plc
| 1 day | -0.39% | ||
| 1 week | +4.83% | ||
| Current month | +5.35% | ||
| 1 month | +10.26% | ||
| 3 months | +26.96% | ||
| 6 months | +50.48% | ||
| Current year | +49.34% |
| 1 week | 242.11 |  | 256.75 |
| 1 month | 224.95 | | 256.75 |
| Current year | 156.95 | | 256.75 |
| 1 year | 105 | | 256.75 |
| 3 years | 95.49 | | 256.75 |
| 5 years | 95.49 | | 256.75 |
| 10 years | 86.88 | | 256.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Renée Galá
CEO | Chief Executive Officer | 54 | 2025-08-10 |
Philip Johnson
DFI | Director of Finance/CFO | 62 | 2024-02-29 |
Mary Henderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 2023-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Cozadd
CHM | Chairman | 62 | 2003-02-28 |
Seamus Mulligan
BRD | Director/Board Member | 65 | 2012-01-17 |
Rick Winningham
BRD | Director/Board Member | 66 | 2009-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/1/26 | Sell | Founder | -6,000 | 0.0096% | ||
| 6/30/26 | Tax | General Counsel | -2,678 | 0.0043% | ||
| 6/30/26 | Tax | Chief Financial Officer | -3,343 | 0.0053% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.39% | +4.83% | +116.35% | +93.93% | 16.01B | |
| +0.86% | +2.30% | +49.71% | +158.86% | 1,057B | |
| +1.59% | +5.37% | +55.77% | +54.77% | 624B | |
| +0.95% | +1.95% | +36.11% | +80.44% | 454B | |
| +1.60% | +7.09% | +35.90% | +29.32% | 341B | |
| -0.60% | +2.95% | +36.28% | +39.04% | 297B | |
| -0.14% | +0.33% | +18.70% | +17.64% | 262B | |
| +0.09% | -4.53% | -27.60% | -42.19% | 215B | |
| +1.22% | +1.20% | +21.61% | +60.14% | 201B | |
| -1.18% | -5.13% | +13.87% | +60.35% | 162B | |
| Average | +0.15% | +1.22% | +35.67% | +55.23% | 363B | |
| Weighted average by Cap. | +0.12% | +1.58% | +36.97% | +76.91% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.51B 3.97B 3.69B 3.39B 6.36B 436B 6.46B 43.82B 17.11B 214B 16.94B 16.57B 739B | 4.84B 4.26B 3.96B 3.63B 6.82B 467B 6.94B 47.02B 18.36B 229B 18.17B 17.78B 793B |
| Net income | 1.02B 900M 836M 768M 1.44B 98.77B 1.47B 9.93B 3.88B 48.41B 3.84B 3.76B 168B | 1.07B 939M 873M 802M 1.5B 103B 1.53B 10.37B 4.05B 50.53B 4.01B 3.92B 175B |
| Net Debt | 1.7B 1.49B 1.39B 1.28B 2.39B 164B 2.43B 16.49B 6.44B 80.38B 6.37B 6.24B 278B | 15.43M 13.57M 12.62M 11.58M 21.74M 1.49B 22.11M 150M 58.51M 730M 57.92M 56.67M 2.53B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | US$253.87 | -0.39% | 538,211 |
| 26-07-23 | US$254.87 | +1.78% | 527,986 |
| 26-07-22 | US$250.41 | -1.50% | 521,018 |
| 26-07-21 | US$254.22 | +4.42% | 810,118 |
| 26-07-20 | US$243.47 | -1.64% | 675,844 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- JAZZ Stock
Select your edition
All financial news and data tailored to specific country editions
